Medical Management of Patients With Symptomatic Carotid Artery Stenosis

Eric T A Lim1, Geoffrey Ying2, Oliver Bernau1

  • 1Department of Vascular Surgery, Waikato Hospital, Hamilton, New Zealand.

Annals of Vascular Surgery
|November 16, 2025
PubMed

Insights

For symptomatic carotid artery stenosis, medical management shows stroke-free survival comparable to surgery. However, patients undergoing carotid intervention had better overall survival rates in this study.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiovascular Medicine

Background:

  • Carotid endarterectomy (CEA) is recommended for symptomatic >50% internal carotid artery stenosis.
  • Limited contemporary data exists on the natural history of medically managed symptomatic carotid artery stenosis.
  • This study aimed to evaluate outcomes for patients with symptomatic carotid artery stenosis managed non-surgically.

Purpose of the Study:

  • To assess the outcomes of patients with symptomatic carotid artery stenosis managed with medical therapy alone.
  • To compare stroke-free survival and all-cause mortality between medically and surgically managed patients.

Main Methods:

  • Prospective observational study conducted at a tertiary vascular referral center (June 2019 - January 2024).
  • Surgical intervention threshold set at ≥70-99% stenosis for symptomatic internal carotid artery.
  • Primary outcomes: stroke-free survival and all-cause mortality, analyzed using Kaplan-Meier methods.

Main Results:

  • Out of 280 patients, 29.2% (63) were managed medically; 69.4% (150) underwent CEA.
  • Medically managed patients experienced a 4.8% rate of further ipsilateral ischemic stroke.
  • At 4 years, stroke-free survival was 88% for medical management vs. 88% for surgical intervention; overall survival was 57% vs. 88% respectively.

Conclusions:

  • While carotid intervention improved survival, the risk of future ipsilateral stroke appears similar between medically and surgically managed patients.
  • Further large-scale studies are necessary to definitively compare long-term outcomes of carotid surgery versus medical management for symptomatic carotid artery stenosis.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
223
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
229
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
207
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
354